CHAMPAIGN, Ill. -- Monitoring the progression of multiple sclerosis-related gait issues can be challenging in adults over 50 years old, requiring a clinician to differentiate between problems related ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A novel ...
Hosted on MSN
PoNS therapy shows promise for MS gait deficits
NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 million, announced significant findings from the PoNS Therapeutic Experience ...
A 32-year-old female with relapsing remitting multiple sclerosis (MS) diagnosed 6 years previously presents at hospital in November 2015. She reports difficulty walking, which she says has worsened ...
PoNS is a portable, noninvasive, prescription-only device intended to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and older. The Food and Drug ...
Could a new device called a portable neuromodulation stimulator (PoNS) help improve your mobility and balance with multiple sclerosis? PoNS is a device that delivers mild electrical pulses to two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback